Citations

Clear

1434 citation(s) found for "Uk, Nathan".

Incidence of Brain Metastasis as First Event in Patients with Esophageal Carcinoma: A Report from Three Prospective Alliance Clinical Trials
Smith, Ron S., Foster, Nathan R. , Jatoi, Aminah , Thomé, Stephan D. , Miller, Robert C.

Mayo Clinic

No container title available | July 12, 2022 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-1815992/v1 Get It

Abstract PurposeHistorically, reported incidence of brain metastasis secondary to esophageal carcinoma is low. We sought to determine the incidence of brain metastasis in a contemporary cohort of patients with carcinoma of the esophagus.MethodsData from patients with localized esophageal carcinoma prospectively enrolled on three curative intent Alliance treatment trials (N0044, N0342, N044E) were reviewed including time to diagnosis of first progression event (brain versus other site) and overall survival.ResultsEighty-five patients comprised the cohort of which 85% were male and 86% had adenocarcinoma primary tumor histology. Thirty-nine of the 85 patients had documented progression to any site, and of those, brain metastasis occurred as the first event in 15% (6 of 39). Adenocarcinoma was the primary histology in all 6 patients and tumor grade was high (3 or 4) in 5 of the 6 patients (one not documented). Median time to brain metastasis (9.6 months) versus non-brain metastasis (12.4 months) and median survival after first progression (5.4 months versus 8.1 months, respectively) were not statistically different.ConclusionIn this prospective cohort of patients with esophageal carcinoma, those with high grade adenocarcinoma appear to have a higher incidence of brain metastasis than historically reported. The pattern of brain metastases corroborates recent findings in terms of incidence, predominance of adenocarcinoma primary tumor histology, timing after diagnosis, and overall survival. Further study to confirm these findings, as well as the value of baseline, restaging and follow-up cranial imaging for brain metastasis is recommended.ClinicalTrials.gov Identifiers: NCT00022139 (NCCTG N0044); NCT00100945 (NCCTG N0342), and NCT00100945 (NCCTG N044E)
Inflammatory biomarkers, multi-morbidity, and biologic aging
Rocca, Walter A. , Jacobson, Debra J., McGree, Michaela E. , St Sauver, Jennifer L , Rocca, Walter, LeBrasseur, Nathan, Chamberlain, Alanna, Jacobson, Debra, McGree, Michaela, Mielke, Michelle, Sauver, Jennifer L. St. , LeBrasseur, Nathan K. , Chamberlain, Alanna M. , Olson, Janet E. , Mielke, Michelle M.

Mayo Clinic

Journal of International Medical Research | July 7, 2022 | Volume: 50 | Issue: 7 | Pages: No page available

10.1177/03000605221109393 | PMID 35796512 Get It

Objectives To study the association between multi-morbidity percentiles, which is a measure of clinical aging, and interleukin (IL)-6, IL-10, and tumor necrosis factor (TNF)-α. Methods Participants 50 to 95 years of age from the Mayo Clinic Study of Aging were assigned age- and sex-specific multi-morbidity percentiles using look-up tables that were reported previously (n = 1646). Percentiles were divided into quintiles for analysis. Plasma IL-6, IL-10, and TNF-α levels were measured in 1595 participants. Median inflammatory marker levels were compared across multi-morbidity quintiles using nonparametric tests. Results People with higher multi-morbidity percentiles had significantly higher IL-6 and TNF-α levels compared with those with lower multi-morbidity percentiles. Tests for trend across five multi-morbidity quintiles were significant among women for IL-6 and among participants 70 years of age or older for IL-6 and TNF-α. IL-10 was not associated with multi-morbidity percentiles. Conclusions Multi-morbidity percentiles may be a useful clinical index of biological age for future studies, particularly in women and people 70 years of age and older.
Association of outpatient use of renin–angiotensin–aldosterone system blockers on outcomes of acute respiratory illness during the COVID-19 pandemic: a cohort study
Jeffery, Molly M. , Silva, Lucas Oliveira J. e , Bellolio, Fernanda , Jeffery, Molly Moore , Oliveira J E Silva, Lucas , Dempsey, Timothy M , Limper, Andrew, Bellolio, M Fernanda , Garovic, Vesna D. , Dempsey, Timothy , Limper, Andrew H. , Cummins, Nathan W.

Mayo Clinic

BMJ Open | July 6, 2022 | Volume: 12 | Issue: 7 | Pages: e060305

10.1136/bmjopen-2021-060305 | PMID 35793915 Get It

Objectives Evaluate the associations between patients taking ACE inhibitors and angiotensin receptor blockers (ARBs) and their clinical outcomes after an acute viral respiratory illness (AVRI) due to COVID-19. Design Retrospective cohort. Setting The USA; 2017–2018 influenza season, 2018–2019 influenza season, and 2019–2020 influenza/COVID-19 season. Participants People with hypertension (HTN) taking an ACEi, ARB or other HTN medications, and experiencing AVRI. Main outcome measures Change in hospital admission, intensive care unit (ICU) or coronary care unit (CCU), acute respiratory distress (ARD), ARD syndrome (ARDS) and all-cause mortality, comparing COVID-19 to pre-COVID-19 influenza seasons. Results The cohort included 1 059 474 episodes of AVRI (653 797 filled an ACEi or ARB, and 405 677 other HTN medications). 58.6% were women and 72.9% with age ≥65. The ACEi/ARB cohort saw a larger increase in risk in the COVID-19 influenza season than the other HTN medication cohort for four out of five outcomes, with an additional 1.5 percentage point (pp) increase in risk of an inpatient stay (95% CI 1.2 to 1.9 pp) and of ICU/CCU use (95% CI 0.3 to 2.7 pp) as well as a 0.7 pp (0.1 to 1.2 pp) additional increase in risk of ARD and 0.9 pp (0.4 to 1.3 pp) additional increase in risk of ARDS. There was no statistically significant difference in the absolute risk of death (−0.2 pp, 95% CI −0.4 to 0.1 pp). However, the relative risk of death in 2019/2020 versus 2017/2018 for the ACEi/ARB group was larger (1.40 (1.36 to 1.44)) than for the other HTN medication cohort (1.24 (1.21 to 1.28)). Conclusions People with AVRI using ACEi/ARBs for HTN had a greater increase in poor outcomes during the COVID-19 pandemic than those using other medications to treat HTN. The small absolute magnitude of the differences likely does not support changes in clinical practice.
Exercise Counters the Age-Related Accumulation of Senescent Cells
Zhang, Xu , Englund, Davis A. , Aversa, Zaira, Jachim, Sarah K. , White, Thomas A. , Zhang, Xu , LeBrasseur, Nathan K. , Englund, Davis A.

Mayo Clinic

Exercise and Sport Sciences Reviews | July 1, 2022 | Volume: 50 | Issue: 4 | Pages: 213-221

10.1249/jes.0000000000000302 | PMID 35776782 Get It

We propose the beneficial effects of exercise are in part mediated through the prevention and elimination of senescent cells. Exercise counters multiple forms of age-related molecular damage that initiate the senescence program and activates immune cells responsible for senescent cell clearance. Preclinical and clinical evidence for exercise as a senescence-targeting therapy and areas needing further investigation are discussed.
Perioperative risk stratification of spine trauma patients with ankylosing spinal disorders: a comparison of 3 quantitative indices
Lakomkin, Nikita , Mikula, Anthony L. , Wellings, Elizabeth P. , Scheitler, Kristen M. , Pennington, Zach , Lee, Nathan J. , Freedman, Brett A. , Sebastian, Arjun S. , Fogelson, Jeremy L. , Bydon, Mohamad , Elder, Benjamin D. , Wellings, Elizabeth, Pennington, Zach , Pinter, Zachariah W. , Alvi, Mohammed Ali , Clarke, Michelle J.

Mayo Clinic

Journal of Neurosurgery: Spine | July 1, 2022 | Volume: 37 | Issue: 5 | Pages: 722-728

10.3171/2022.4.spine211449 | PMID 35623371 Get It

OBJECTIVE Patients with ankylosing spinal disorders (ASDs), including ankylosing spondylitis (AS) and diffuse idiopathic skeletal hyperostosis (DISH), have been shown to experience significantly increased rates of postoperative complications. Despite this, very few risk stratification tools have been validated for this population. As such, the purpose of this study was to identify predictors of adverse events and mortality in ASD patients undergoing surgery for 3-column fractures. METHODS All adult patients with a documented history of AS or DISH who underwent surgery for a traumatic 3-column fracture between 2000 and 2020 were identified. Perioperative variables, including comorbidities, time to diagnosis, and number of fused segments, were collected. Three instruments, including the Charlson Comorbidity Index (CCI), modified frailty index (mFI), and Injury Severity Score (ISS), were computed for each patient. The primary outcomes of interest included 1-year mortality, as well as postoperative complications. RESULTS A total of 108 patients were included, with a mean ± SD age of 73 ± 11 years. Of these, 41 (38%) experienced at least 1 postoperative complication and 22 (20.4%) died within 12 months after surgery. When the authors controlled for potential known confounders, the CCI score was significantly associated with postoperative adverse events (OR 1.20, 95% CI 1.00–1.42, p = 0.045) and trended toward significance for mortality (OR 1.19, 95% CI 0.97–1.45, p = 0.098). In contrast, mFI score and ISS were not significantly predictive of either outcome. CONCLUSIONS Complications in spine trauma patients with ASD may be driven by comorbidity burden rather than operative or injury-related factors. The CCI may be a valuable tool for the evaluation of this unique population.
SHP2 inhibition enhances Yes-associated protein–mediated liver regeneration in murine partial hepatectomy models
Watkins, Ryan , Buckarma, EeeLN H. , Tomlinson, Jennifer L. , McCabe, Chantal E. , Yonkus, Jennifer A. , Werneburg, Nathan W., Bayer, Rachel L., Starlinger, Patrick , Robertson, Keith D. , Wang, Chen , Smoot, Rory L. , Smoot, Rory L , Robertson, Keith D , Wang, Chen , Starlinger, Patrick , Yonkus, Jennifer A , Buckarma, EeeLN , Tomlinson, Jennifer , Gores, Gregory J.

Mayo Clinic

JCI Insight | June 28, 2022 | Volume: 7 | Issue: 15 | Pages: No page available

10.1172/jci.insight.159930 | PMID 35763355 Get It

Disrupted liver regeneration following hepatectomy represents an “undruggable” clinical challenge associated with poor patient outcomes. Yes-associated protein (YAP), a transcriptional coactivator that is repressed by the Hippo pathway, is instrumental in liver regeneration. We have previously described an alternative, Hippo-independent mechanism of YAP activation mediated by downregulation of protein tyrosine phosphatase nonreceptor type 11 (PTPN11, also known as SHP2) inhibition. Herein, we examined the effects of YAP activation with a selective SHP1/SHP2 inhibitor, NSC-87877, on liver regeneration in murine partial hepatectomy models. In our studies, NSC-87877 led to accelerated hepatocyte proliferation, improved liver regeneration, and decreased markers of injury following partial hepatectomy. The effects of NSC-87877 were lost in mice with hepatocyte-specific Yap/Taz deletion, and this demonstrated dependence on these molecules for the enhanced regenerative response. Furthermore, administration of NSC-87877 to murine models of nonalcoholic steatohepatitis was associated with improved survival and decreased markers of injury after hepatectomy. Evaluation of transcriptomic changes in the context of NSC-87877 administration revealed reduction in fibrotic signaling and augmentation of cell cycle signaling. Cytoprotective changes included downregulation of Nr4a1 , an apoptosis inducer. Collectively, the data suggest that SHP2 inhibition induces a pro-proliferative and cytoprotective enhancement of liver regeneration dependent on YAP.
A minimum SNR criterion for computed tomography object detection in the projection domain
Hsieh, Scott S. , Yu, Lifeng , Huber, Nathan R. , Leng, Shuai , Yu, Lifeng , McCollough, Cynthia H.

Mayo Clinic

Medical Physics | June 27, 2022 | Volume: 49 | Issue: 8 | Pages: 4988-4998

10.1002/mp.15832 | PMID 35754205 Get It

Abstract Background A common rule of thumb for object detection is the Rose criterion, which states that a signal must be five standard deviations above background to be detectable to a human observer. The validity of the Rose criterion in CT imaging is limited due to the presence of correlated noise. Recent reconstruction and denoising methodologies are also able to restore apparent image quality in very noisy conditions, and the ultimate limits of these methodologies are not yet known. Purpose To establish a lower bound on the minimum achievable signal‐to‐noise ratio (SNR) for object detection, below which detection performance is poor regardless of reconstruction or denoising methodology. Methods We consider a numerical observer that operates on projection data and has perfect knowledge of the background and the objects to be detected, and determine the minimum projection SNR that is necessary to achieve predetermined lesion‐level sensitivity and case‐level specificity targets. We define a set of discrete signal objects that encompasses any lesion of interest and could include lesions of different sizes, shapes, and locations. The task is to determine which object of is present, or to state the null hypothesis that no object is present. We constrain each object in to have equivalent projection SNR and use Monte Carlo methods to calculate the required projection SNR necessary. Because our calculations are performed in projection space, they impose an upper limit on the performance possible from reconstructed images. We chose to be a collection of elliptical or circular low contrast metastases and simulated detection of these objects in a parallel beam system with Gaussian statistics. Unless otherwise stated, we assume a target of 80% lesion‐level sensitivity and 80% case‐level specificity and a search field of view that is 6 cm by 6 cm by 10 slices. Results When contains only a single object, our problem is equivalent to two‐alternative forced choice (2AFC) and the required projection SNR is 1.7. When consists of circular 6‐mm lesions at different locations in space, the required projection SNR is 5.1. When is extended to include ellipses and circles of different sizes, the required projection SNR increases to 5.3. The required SNR increases if the sensitivity target, specificity target, or search field of view increases. Conclusions Even with perfect knowledge of the background and target objects, the ideal observer still requires an SNR of approximately 5. This is a lower bound on the SNR that would be required in real conditions, where the background and target objects are not known perfectly. Algorithms that denoise lesions with less than 5 projection SNR, regardless of the denoising methodology, are expected to show vanishing effects or false positive lesions.
Incidence and management of pleural effusions in patients with Wilms tumor: A Pediatric Surgical Oncology Research Collaborative study
Al‐Hadidi, Ameer , Rinehardt, Hannah , Sutthatarn, Pattamon , Condon, Sienna, Chen, Stephanie , Wong‐Michalak, Shannon , Short, Scott S. , Meyers, Rebecka L. , Johnston, Michael E. , Zens, Tiffany , Dasgupta, Roshni , Calabro, Kristen , Piché, Nelson , Callas, Hannah, McKay, Katlyn G. , Lovvorn, Harold N. , Tracy, Elisabeth T. , Lund, Sarah , Polites, Stephanie F. , Davidson, Jacob , Dhooma, Janel, Seemann, Natashia M. , Marquart, John , Gainer, Haley , Lal, Dave R. , Rich, Barrie S. , Glick, Richard D. , Maloney, Lauren , Radu, Stephani, Fialkowski, Elizabeth , Kwok, Pei En , Romao, Rodrigo , Newman, Erika A. , Diehl, Thomas M. , Polcz, Valerie E., Petroze, Robin T. , Aldrink, Jennifer H. , Lautz, Timothy , Lund, Sarah B, Tracy, Elisabeth T , Aldrink, Jennifer H , Dasgupta, Roshni , Talbot, Lindsay J , Murphy, Andrew J. , Whitlock, Richard S. , Naik‐Mathuria, Bindi , Utria, Alan Fremder , Rothstein, David H. , Kim, Eugene S. , Kastenberg, Zachary J. , Malek, Marcus M. , Lautz, Timothy B. , Commander, Sarah Jane , Radu, Stephanie , Rubalcava, Nathan S. , Ehrlich, Peter F. , Le, Hau D. , Stanek, Joseph

Mayo Clinic

International Journal of Cancer | June 24, 2022 | Volume: 151 | Issue: 10 | Pages: 1696-1702

10.1002/ijc.34188 | PMID 35748343 Get It

AbstractWilms tumor (WT) is the most common renal malignancy in children. Children with favorable histology WT achieve survival rates of over 90%. Twelve percent of patients present with metastatic disease, most commonly to the lungs. The presence of a pleural effusion at the time of diagnosis of WT may be noted on staging imaging; however, minimal data exist regarding the significance and prognostic importance of this finding. The objectives of our study are to identify the incidence of pleural effusions in patients with WT, and to determine the potential impact on oncologic outcomes. A multi‐institutional retrospective review was performed from January 2009 to December 2019, including children with WT and a pleural effusion on diagnostic imaging treated at Pediatric Surgical Oncology Research Collaborative (PSORC) participating institutions. Of 1259 children with a new WT diagnosis, 94 (7.5%) had a pleural effusion. Patients with a pleural effusion were older than those without (median 4.3 vs 3.5 years; P = .004), and advanced stages were more common (local stage III 85.9% vs 51.9%; P < .0001). Only 14 patients underwent a thoracentesis for fluid evaluation; 3 had cytopathologic evidence of malignant cells. Event‐free and overall survival of all children with WT and pleural effusions was 86.2% and 91.5%, respectively. The rate and significance of malignant cells present in pleural fluid is unknown due to low incidence of cytopathologic analysis in our cohort; therefore, the presence of an effusion does not appear to necessitate a change in therapy. Excellent survival can be expected with current stage‐specific treatment regimens.
80. Examining Chest Femininity of Hormone Treated Vs. Surgically Augmented Transgender Women
Zhu, Agnes , Callori, Steven , Boonipat, Thanapoom , Hebel, Nathan , Martinez‐Jorge, Jorys

Mayo Clinic

Plastic and Reconstructive Surgery - Global Open | June 23, 2022 | Volume: 10 | Issue: 6S | Pages: 53-53

10.1097/01.gox.0000842640.47650.27 Get It

85. Artificial Intelligence in the Objective Comparison of Endoscopic Browlift Techniques
Hebel, Nathan , Boonipat, Thanapoom , Lin, Jason, Shapiro, Daniel , Mardini, Samir

Mayo Clinic

Plastic and Reconstructive Surgery - Global Open | June 23, 2022 | Volume: 10 | Issue: 6S | Pages: 56-56

10.1097/01.gox.0000842660.72097.95 Get It